Young Survivors of Cancer at Increased Risk of Endocrine Disease

MedicalResearch.com Interview with:
“Cancer awareness” by Susan Roberts is licensed under CC BY 2.0Mette Vestergaard Jensen, MD

Danish Cancer Society Research Center

MedicalResearch.com: What is the background for this study?

Response: Cancer survival rates have improved and it is necessary to explore the long-term consequences of cancer treatment. Adolescents and young adults with cancer are at risk for several therapy-related late effects; however, these have not been studied extensively. We investigatet the lifetime risks of endocrine late effects of cancer and cancer treatment in adolescent and young adult cancer s

Continue reading

Cancer Survivors: Discussions of Survivorship Have Room For Improvement

Danielle Blanch Hartigan, PhD, MPH Cancer Prevention Fellow National Cancer InstituteMedicalResearch.com Interview with:
Danielle Blanch Hartigan, PhD, MPH
Cancer Prevention Fellow
National Cancer Institute
MedicalResearch.com: What are the main findings of the study?

Dr. Blanch-Hartigan: Results from this nationally-representative survey of oncologists and PCPs suggest that discussion of survivorship care planning with cancer survivors does not always occur. Training and knowledge specific to survivorship care and coordinated care between PCPs and oncologists were associated with increased survivorship discussions with survivors.

Continue reading

Cancer Survivors in the United States: Prevalence across the Survivorship Trajectory and Implications for Care

Janet S. de Moor, PhD, MPH  Program Director, Office of Cancer Survivorship Division of Cancer Control and Population Sciences National Cancer Institute/National Institutes of Health Bethesda, MD 20891-8336MedicalResearch.com Interview with Janet S. de Moor, PhD, MPH

Program Director, Office of Cancer Survivorship
Division of Cancer Control and Population Sciences
National Cancer Institute/National Institutes of Health
Bethesda, MD 20891-8336

MedicalResearch.com: What are the main findings of the study? 

Dr. de Moor: The number of people who have been diagnosed with cancer during their lifetime has been steadily increasing.  As of January 1, 2012, approximately 13.7 million cancer survivors were living in the United States with projected prevalence to approach 18 million by 2022.  Women with breast cancer and men with prostate cancer represent the two largest groups of cancer survivors, accounting for 22% and 20% of the population respectively.  Sixty-four percent of cancer survivors have survived 5 years or more; 40% have survived 10 years or more; and 15% have survived 20 years or more after diagnosis.  Over the next decade, the number of people who have lived 5 years or more after their cancer diagnosis is projected to increase approximately 37% to 11.9 million.
Continue reading